Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Obesity-associated diseases account for a large portion of public health challenges. Among obesity-related disorders, a direct and independent relationship has been ascertained for colorectal cancer (CRC). The evidence that adipocyte hypertrophy and excessive adipose tissue accumulation (mainly visceral) can promote pathogenic adipocyte and adipose tissue-related diseases, has led to formulate the concept of "adiposopathy", defined as adipocyte and adipose tissue dysfunction that contributes to metabolic syndrome. Adipose tissue can, indeed, be regarded as an important and highly active player of the innate immune response, in which cytokine/ adipokine secretion is responsible for a paracrine loop between adipocytes and macrophages, thus contributing to the systemic chronic low-grade inflammation associated with visceral obesity, which represents favorable niche for tumor development. The adipocyte itself participates as a central mediator of this inflammatory response in obese individuals by secreting hormones, growth factors and proinflammatory cytokines, which are of particular relevance for the pathogenesis of CRC. Among adipocyte-secreted hormones, the most relevant to colorectal tumorigenesis are adiponectin, leptin, resistin and ghrelin. All these molecules have been involved in cell growth and proliferation, as well as tumor angiogenesis and it has been demonstrated that their expression changes from normal colonic mucosa to adenoma and adenocarcinoma, suggesting their involvement in multistep colorectal carcinogenesis. These findings have led to the hypothesis that an unfavorable adipokine profile, with a reduction of those with an anti-inflammatory and anti-cancerous activity, might serve as a prognostic factor in CRC patients and that adipokines or their analogues/antagonists might become useful agents in the management or chemoprevention of CRC.

Original languageEnglish
Pages (from-to)5177-5190
Number of pages14
JournalWorld Journal of Gastroenterology
Volume20
Issue number18
DOIs
Publication statusPublished - May 14 2014

Fingerprint

Adipokines
Adipocytes
Colorectal Neoplasms
Obesity
Adipose Tissue
Neoplasms
Carcinogenesis
Hormones
Cytokines
Resistin
Ghrelin
Abdominal Obesity
Adiponectin
Chemoprevention
Leptin
Innate Immunity
Adenoma
Hypertrophy
Intercellular Signaling Peptides and Proteins
Mucous Membrane

Keywords

  • Adiponectin
  • Colorectal cancer
  • Cytokines
  • Ghrelin
  • Inflammation
  • Leptin
  • Obesity
  • Resistin

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Obesity and colorectal cancer : Role of adipokines in tumor initiation and progression. / Riondino, Silvia; Roselli, Mario; Palmirotta, Raffaele; Della-Morte, David; Ferroni, Patrizia; Guadagni, Fiorella.

In: World Journal of Gastroenterology, Vol. 20, No. 18, 14.05.2014, p. 5177-5190.

Research output: Contribution to journalArticle

@article{fdc2953aeedc4781817bf2a098382f77,
title = "Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression",
abstract = "Obesity-associated diseases account for a large portion of public health challenges. Among obesity-related disorders, a direct and independent relationship has been ascertained for colorectal cancer (CRC). The evidence that adipocyte hypertrophy and excessive adipose tissue accumulation (mainly visceral) can promote pathogenic adipocyte and adipose tissue-related diseases, has led to formulate the concept of {"}adiposopathy{"}, defined as adipocyte and adipose tissue dysfunction that contributes to metabolic syndrome. Adipose tissue can, indeed, be regarded as an important and highly active player of the innate immune response, in which cytokine/ adipokine secretion is responsible for a paracrine loop between adipocytes and macrophages, thus contributing to the systemic chronic low-grade inflammation associated with visceral obesity, which represents favorable niche for tumor development. The adipocyte itself participates as a central mediator of this inflammatory response in obese individuals by secreting hormones, growth factors and proinflammatory cytokines, which are of particular relevance for the pathogenesis of CRC. Among adipocyte-secreted hormones, the most relevant to colorectal tumorigenesis are adiponectin, leptin, resistin and ghrelin. All these molecules have been involved in cell growth and proliferation, as well as tumor angiogenesis and it has been demonstrated that their expression changes from normal colonic mucosa to adenoma and adenocarcinoma, suggesting their involvement in multistep colorectal carcinogenesis. These findings have led to the hypothesis that an unfavorable adipokine profile, with a reduction of those with an anti-inflammatory and anti-cancerous activity, might serve as a prognostic factor in CRC patients and that adipokines or their analogues/antagonists might become useful agents in the management or chemoprevention of CRC.",
keywords = "Adiponectin, Colorectal cancer, Cytokines, Ghrelin, Inflammation, Leptin, Obesity, Resistin",
author = "Silvia Riondino and Mario Roselli and Raffaele Palmirotta and David Della-Morte and Patrizia Ferroni and Fiorella Guadagni",
year = "2014",
month = "5",
day = "14",
doi = "10.3748/wjg.v20.i18.5177",
language = "English",
volume = "20",
pages = "5177--5190",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "18",

}

TY - JOUR

T1 - Obesity and colorectal cancer

T2 - Role of adipokines in tumor initiation and progression

AU - Riondino, Silvia

AU - Roselli, Mario

AU - Palmirotta, Raffaele

AU - Della-Morte, David

AU - Ferroni, Patrizia

AU - Guadagni, Fiorella

PY - 2014/5/14

Y1 - 2014/5/14

N2 - Obesity-associated diseases account for a large portion of public health challenges. Among obesity-related disorders, a direct and independent relationship has been ascertained for colorectal cancer (CRC). The evidence that adipocyte hypertrophy and excessive adipose tissue accumulation (mainly visceral) can promote pathogenic adipocyte and adipose tissue-related diseases, has led to formulate the concept of "adiposopathy", defined as adipocyte and adipose tissue dysfunction that contributes to metabolic syndrome. Adipose tissue can, indeed, be regarded as an important and highly active player of the innate immune response, in which cytokine/ adipokine secretion is responsible for a paracrine loop between adipocytes and macrophages, thus contributing to the systemic chronic low-grade inflammation associated with visceral obesity, which represents favorable niche for tumor development. The adipocyte itself participates as a central mediator of this inflammatory response in obese individuals by secreting hormones, growth factors and proinflammatory cytokines, which are of particular relevance for the pathogenesis of CRC. Among adipocyte-secreted hormones, the most relevant to colorectal tumorigenesis are adiponectin, leptin, resistin and ghrelin. All these molecules have been involved in cell growth and proliferation, as well as tumor angiogenesis and it has been demonstrated that their expression changes from normal colonic mucosa to adenoma and adenocarcinoma, suggesting their involvement in multistep colorectal carcinogenesis. These findings have led to the hypothesis that an unfavorable adipokine profile, with a reduction of those with an anti-inflammatory and anti-cancerous activity, might serve as a prognostic factor in CRC patients and that adipokines or their analogues/antagonists might become useful agents in the management or chemoprevention of CRC.

AB - Obesity-associated diseases account for a large portion of public health challenges. Among obesity-related disorders, a direct and independent relationship has been ascertained for colorectal cancer (CRC). The evidence that adipocyte hypertrophy and excessive adipose tissue accumulation (mainly visceral) can promote pathogenic adipocyte and adipose tissue-related diseases, has led to formulate the concept of "adiposopathy", defined as adipocyte and adipose tissue dysfunction that contributes to metabolic syndrome. Adipose tissue can, indeed, be regarded as an important and highly active player of the innate immune response, in which cytokine/ adipokine secretion is responsible for a paracrine loop between adipocytes and macrophages, thus contributing to the systemic chronic low-grade inflammation associated with visceral obesity, which represents favorable niche for tumor development. The adipocyte itself participates as a central mediator of this inflammatory response in obese individuals by secreting hormones, growth factors and proinflammatory cytokines, which are of particular relevance for the pathogenesis of CRC. Among adipocyte-secreted hormones, the most relevant to colorectal tumorigenesis are adiponectin, leptin, resistin and ghrelin. All these molecules have been involved in cell growth and proliferation, as well as tumor angiogenesis and it has been demonstrated that their expression changes from normal colonic mucosa to adenoma and adenocarcinoma, suggesting their involvement in multistep colorectal carcinogenesis. These findings have led to the hypothesis that an unfavorable adipokine profile, with a reduction of those with an anti-inflammatory and anti-cancerous activity, might serve as a prognostic factor in CRC patients and that adipokines or their analogues/antagonists might become useful agents in the management or chemoprevention of CRC.

KW - Adiponectin

KW - Colorectal cancer

KW - Cytokines

KW - Ghrelin

KW - Inflammation

KW - Leptin

KW - Obesity

KW - Resistin

UR - http://www.scopus.com/inward/record.url?scp=84900394642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900394642&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i18.5177

DO - 10.3748/wjg.v20.i18.5177

M3 - Article

C2 - 24833848

AN - SCOPUS:84900394642

VL - 20

SP - 5177

EP - 5190

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 18

ER -